Document:USA 21 CFR Part 54 09-Apr-2025: Difference between revisions
From GxPlex
gxplex>GxPlexBot Import from GxPlex Excel |
Remove static References table, superseded by live #ask in Template:DocumentData (GxPlexBot) |
||
| (4 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
{{DocumentData | |||
|reference=USA 21 CFR Part 54 09-Apr-2025 | |reference=USA 21 CFR Part 54 09-Apr-2025 | ||
|validity_area=USA | |validity_area=USA | ||
| Line 37: | Line 18: | ||
|contributors= | |contributors= | ||
}} | }} | ||
Latest revision as of 14:15, 16 July 2026
| Document information | |
|---|---|
| Reference | USA 21 CFR Part 54 09-Apr-2025 |
| Validity area | USA |
| Scope(s) | G |
| Document name | 21 CFR Part 54 |
| Version / Revision | 09-Apr-2025 |
| Status | Current |
| Document type | Legal act |
| Language(s) | EN |
| Description | Title 21 —Food and Drugs
Chapter I —Food and Drug Administration, Department of Health and Human Services Subchapter A—General Part 54 Financial Disclosure by Clinical Investigators https://www.ecfr.gov/current/title-21 |
| Official source | Official link |
| Restricted access | No |
| Submitted by | Florian Adragna |
| Contributors | |
References
| Scope | Document part | Language | Preview | |
|---|---|---|---|---|
| USA 21 CFR Part 54 09-Apr-2025 § 54.1-001 | G | § 54.1 | EN | § 54.1 Purpose. (a) The Food and Drug Administration (FDA) evaluates clinical studies submitted in marketing applications, required by law, for new hu… |
| USA 21 CFR Part 54 09-Apr-2025 § 54.1-002 | G | § 54.1 | EN | § 54.1 Purpose. (a) The Food and Drug Administration (FDA) evaluates clinical studies submitted in marketing applications, required by law, for new hu… |
| USA 21 CFR Part 54 09-Apr-2025 § 54.4 disclosure | G | § 54.4 disclosure | EN | § 54.4 Certification and disclosure requirements.
[…] Clinical investigators subject to investigational new drug or investigational device exemption r… |
| USA 21 CFR Part 54 09-Apr-2025 § 54.4 list of investigators | G | § 54.4 list of investigators | EN | § 54.4 Certification and disclosure requirements. For purposes of this part, an applicant must submit a list of all clinical investigators who conduct… |
| USA 21 CFR Part 54 09-Apr-2025 § 54.6 | G | § 54.6 | EN | § 54.6 Recordkeeping and record retention. (a) Financial records of clinical investigators to be retained. An applicant who has submitted a marketing … |
